Form D · Other Health Care
AmorSui Inc.
New York, NY · CIK 0002148382
Offering snapshot reported Sep 23, 2026 · SEC filing
- Reported sold
- $2.74M Offering amount: $2.74M
- Investors reported
- 39 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 6, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2026 | Initial | $2,740,932 | No comparison | 39 | SEC filing |
Offering details
- Securities
- Debt, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-598602
Simple Agreements for future Equity (SAFEs).
Source: Form D, filed Sep 23, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Beau Wangtrakuldee | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
500 7 Th Avenue
New York, NY, 10018
New York, NY, 10018